1439 - Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Page last updated: 29 September 2017

Application Detail



Description of Medical Service

iAluRil is instilled into the bladder and held for as long as possible (30 + mins).

Description of Medical Condition

iAluRil therapy is indicated to re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as Painful Bladder Syndrome (PBS), interstitial cystitis (IC), treatment and prevention of recurrent urinary tract infection, cystitis as a result of Bacillus Calmette Guerin therapy, or chemical and radiation therapy.
iAluRil therapy is also indicated in the cases where the loss of the glycosaminoglycan layers (GAGs) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

Final Protocol (PDF 782 KB)
Final Protocol (Word 1093 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 283 KB)
Public Summary Document (Word 98 KB)

Meetings for this Application


11 - 12 August 2016


8 June 2017


27 July 2017